- Loyola to be the First Chicago Center to Produce CAR T-Cells
As Loyola participates in CAR T-cell clinical trials, the T cells collected will be sent to Loyola's clean lab to be modified to target and fight cancer cells. No other center in Chicago is able to modify these T cells in-house. This could create less toxic and less expensive T cells for leukemia and lymphoma patients.
- New Breast Cancer Treatment that Reduces Side Effects to be Offered
A new breast cancer radiation therapy that shortens the treatment times by three weeks, while reducing side effects, will now be available for select breast cancer patients at Loyola Medicine at Palos Health South Campus.
COVID-19 (Coronavirus) Update
Cardinal Bernardin Cancer Center
Find a Doctor
Our Cancer Care Team
Your dedicated Loyola Medicine team may include (from left) Raymond Wynn, MD; Muaiad Kittaneh, MD; and Hanh Mai, DO.
Cardinal Bernardin Cancer Center News
"My husband and I felt an immediate connection with Dr. Eberhardt. Dr. Eberhardt was a second opinion, but he was our first choice in the end, by far." - Jennifer Anderson, Loyola patient